Lineage Cell Therapeutics Depreciation & Amortization 2011-2026 | LCTX

Annual Depreciation & Amortization Lineage Cell Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
699 K	587 K	562 K	582 K	663 K	823 K	1 M	1.08 M	947 K	1.18 M	1.08 M	1.05 M	657 K	386 K	373 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.18 M	373 K	778 K

Quarterly Depreciation & Amortization Lineage Cell Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
178 K	171 K	164 K	-	141 K	142 K	153 K	-	143 K	138 K	138 K	-	145 M	146 M	150 K	-	504 K	338 K	174 K	-	200 K	210 K	212 K	-	253 K	244 K	269 K	-	254 K	279 K	281 K	-	249 K	205 K	216 K	-	996 K	748 K	429 K	-	776 K	512 K	263 K	-	794 K	523 K	257 K	-	420 K	113 K	113 K	-	284 K	88.7 K	88.7 K	-	261 K	128 K	65.2 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
146 M	65.2 K	6.74 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	18.4 M	$ 3.57	0.14 %	$ 1.07 B	Canada
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.79	0.04 %	$ 4.31 M	China
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 6.45	-2.71 %	$ 177 M	Israel
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
BioCardia BCDA	84 K	$ 1.3	2.36 %	$ 27.5 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	416 K	$ 6.08	0.5 %	$ 495 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 3.49	-2.51 %	$ 7.59 B	Israel
Catalyst Biosciences CBIO	2.48 M	$ 11.08	-4.32 %	$ 990 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Anika Therapeutics ANIK	6.43 M	$ 14.49	0.91 %	$ 212 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
CNS Pharmaceuticals CNSP	3.31 K	$ 2.41	-1.63 %	$ 921 K	USA
AVEO Pharmaceuticals AVEO	67 K	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.6	-1.52 %	$ 16.3 M	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.51	-0.33 %	$ 385 M	Britain
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA